Furanizole Injection (Metronidazole)
Metronidazole 500mg
Prescription medication
Albozen Korea Co., Ltd.
MFDS item code 199900910 · Notified 1999.10.02 · Insurance code 652601573
Effective in the treatment of trichomoniasis and anaerobic bacterial infections (such as intra-abdominal, skin, gynecological) and prevention of post-surgical infections.
This medicine is effective in treating parasitic infections such as trichomoniasis and amoebiasis. It is also used for various anaerobic bacterial infections, and helps treat peritonitis, liver abscess, skin and soft tissue infections, gynecological infections such as endometritis and myometritis, ovarian abscesses, bone and joint infections, central nervous system infections such as brain abscess and meningitis, lower respiratory infections such as pneumonia, and several severe infections including endocarditis. It is particularly important for preventing anaerobic infections that can occur after surgery. This drug is effective against anaerobic bacterioides and streptococci and improves various infectious conditions such as sepsis, abscesses, and necrotizing pneumonia. It is a reliable medicine used in the treatment and prevention of such diverse infectious diseases.
(Tablet) Trichomoniasis: For metronidazole, typically administer 250 mg orally twice daily for 10 days in adults. Anaerobic bacterial infections 1) Treatment: Typically for adults, administer 500 mg orally three to four times a day, not exceeding a maximum dose of 4 g per day, for 7 to 10 days. 2) Post-surgical prevention: Administer an initial dose of 1 g, then 250 mg orally three times a day. Amoebiasis: Typically in adults
(Injection) Treatment of anaerobic bacterial infections: In children aged 12 years and older, intravenous administration of 500 mg every 8 hours is the same as for adults; if oral administration is possible, it should be given orally three times a day. For children under 12 years: Daily
This drug should be avoided due to reports of tumor formation in rodent experiments. Systemic administration of this drug in patients with cocaine syndrome may cause severe hepatotoxicity or acute liver failure; therefore, liver function tests must be conducted and cautious usage is required. It should not be administered to patients who are allergic to this drug or its components, those with a history of blood disorders or neurological disorders, mothers in the first trimester of pregnancy, or those taking certain medications. Also, severe side effects may occur when consumed with alcohol, so alcohol should be avoided for at least 3 days during and after treatment. Extra caution is needed for patients with liver dysfunction or pregnant women in the later stages, CNS infection patients, and those requiring sodium restrictions. Various side effects may occur in the digestive system, blood system, skin, and nervous system; therefore, if abnormal symptoms arise, medical personnel should be notified immediately. Patients with severe liver disease may need dosage adjustment as the drug can accumulate in the body, and regular clinical evaluations during treatment are recommended. This drug may affect blood clotting; therefore, patients taking anticoagulants need blood testing and dosage adjustments. There are many interactions with other medications, so inform your doctor or pharmacist if you are taking other drugs, especially avoiding concomitant use with alcohol, disulfiram, and certain antiepileptics. During pregnancy, this medication may affect the fetus; hence, it should not be used in the early months of pregnancy, and nursing should be discontinued while using this drug. In case of overdose, no specific antidote exists, usual treatment will be administered, and this drug should not be mixed with other drugs but is to be used solely for intravenous drip injection. Any remaining drug after usage should be discarded, and if adverse skin reactions occur during administration, the treatment should be stopped immediately.
Urticaria, severe swelling (angioedema), anaphylactic shock, mucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell syndrome), drug reaction with eosinophilia and systemic symptoms (DRESS), acute generalized exanthematous pustulosis (AGEP), hepatitis, jaundice, convulsive seizures, encephalopathy, subacute cerebellar syndrome, severe hepatotoxicity/acute liver failure.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container, avoiding direct sunlight and kept in a cool place. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature, and refrigeration is not necessary. Proper storage will help maintain the drug's effectiveness for a longer period.
Colorless and transparent liquid contained in a clear glass or polypropylene container.
100mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metronidazole 500mg
Prescription medication
Albozen Korea Co., Ltd.

Metronidazole 250mg
Tablet · Prescription medication
H.K. Inno.N Co., Ltd.
Metronidazole 500mg
Prescription medication
JW Pharmaceutical Co., Ltd.
Metronidazole 5000mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
Metronidazole 7.5mg
Prescription medication
BC World Pharmaceutical Co., Ltd.
Metronidazole 0.75g
Prescription medication
Galderma Korea Co., Ltd.
Metronidazole 500mg
Prescription medication
Bentiv Korea Co., Ltd.
Metronidazole
Prescription medication
NanoPharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.